144 related articles for article (PubMed ID: 1426206)
1. A comparison of six different ways of expressing the bronchodilating response in asthma and COPD; reproducibility and dependence of prebronchodilator FEV1.
Dompeling E; van Schayck CP; Molema J; Akkermans R; Folgering H; van Grunsven PM; van Weel C
Eur Respir J; 1992 Sep; 5(8):975-81. PubMed ID: 1426206
[TBL] [Abstract][Full Text] [Related]
2. [A comparison of bronchodilating drugs in the treatment of stable COPD].
Nishimura K; Koyama H; Izumi T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):835-43. PubMed ID: 1385837
[TBL] [Abstract][Full Text] [Related]
3. Measures of reversibility in response to bronchodilators in chronic airflow obstruction: relation to airway calibre.
Weir DC; Sherwood Burge P
Thorax; 1991 Jan; 46(1):43-5. PubMed ID: 1831301
[TBL] [Abstract][Full Text] [Related]
4. [Comparing the bronchodilating effects of ipratropium bromide and theophylline].
Dai L; Li X; Yang Y
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):609-11. PubMed ID: 11477880
[TBL] [Abstract][Full Text] [Related]
5. Inhaled beclomethasone improves the course of asthma and COPD.
Dompeling E; van Schayck CP; Molema J; Folgering H; van Grunsven PM; van Weel C
Eur Respir J; 1992 Sep; 5(8):945-52. PubMed ID: 1426202
[TBL] [Abstract][Full Text] [Related]
6. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
[TBL] [Abstract][Full Text] [Related]
7. [Effect of vaporizing high doses of ipratropium bromide on lung ventilation in patients with chronic obstructive pulmonary disease and bronchial asthma].
Dor A; Krasnowska M; Małolepszy J
Pneumonol Alergol Pol; 1994; 62(1-2):75-9. PubMed ID: 8075617
[TBL] [Abstract][Full Text] [Related]
8. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.
Chhabra SK; Bhatnagar S
Indian J Chest Dis Allied Sci; 2002; 44(2):91-7. PubMed ID: 12026258
[TBL] [Abstract][Full Text] [Related]
9. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study.
Dompeling E; van Schayck CP; van Grunsven PM; van Herwaarden CL; Akkermans R; Molema J; Folgering H; van Weel C
Ann Intern Med; 1993 May; 118(10):770-8. PubMed ID: 8470851
[TBL] [Abstract][Full Text] [Related]
10. The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.
Nishimura K; Koyama H; Ikeda A; Sugiura N; Kawakatsu K; Izumi T
Chest; 1995 Mar; 107(3):718-23. PubMed ID: 7874943
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease.
Matera MG; Cazzola M; Vinciguerra A; Di Perna F; Calderaro F; Caputi M; Rossi F
Pulm Pharmacol; 1995 Dec; 8(6):267-71. PubMed ID: 8819181
[TBL] [Abstract][Full Text] [Related]
12. Acute bronchodilator trials in chronic obstructive pulmonary disease.
Nisar M; Earis JE; Pearson MG; Calverley PM
Am Rev Respir Dis; 1992 Sep; 146(3):555-9. PubMed ID: 1387772
[TBL] [Abstract][Full Text] [Related]
13. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group.
Kerstjens HA; Overbeek SE; Schouten JP; Brand PL; Postma DS
Eur Respir J; 1993 Jun; 6(6):868-76. PubMed ID: 8339808
[TBL] [Abstract][Full Text] [Related]
14. Contribution of ipratropium bromide to the bronchodilator test in patients with chronic obstructive pulmonary disease.
Rodríguez-Carballeira M; Heredia JL; Gomez L; Quintana S; Vinas C
Pulm Pharmacol Ther; 1999; 12(1):43-8. PubMed ID: 10447370
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of bronchodilator effects and site of action of fenoterol and ipratropium in chronic obstructive bronchitis].
Kheir A; Ying Y; Hannhart B; Duvivier C; Peslin R; Polu JM
Rev Mal Respir; 1993; 10(1):9-15. PubMed ID: 8451502
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the bronchodilating efficacies of a novel salbutamol metered dose powder inhaler and a pressurised metered dose aerosol with a spacer.
Seppälä OP; Kari E; Elo J; Löyttyniemi E; Kunkel G
Arzneimittelforschung; 1998 Sep; 48(9):919-23. PubMed ID: 9793619
[TBL] [Abstract][Full Text] [Related]
17. Bronchodilatory responses to formoterol, ipratropium, and their combination in patients with stable COPD.
Sichletidis L; Kottakis J; Marcou S; Constantinidis TC; Antoniades A
Int J Clin Pract; 1999; 53(3):185-8. PubMed ID: 10665129
[TBL] [Abstract][Full Text] [Related]
18. Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP).
Zeiger RS; Dawson C; Weiss S
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):376-87. PubMed ID: 10069869
[TBL] [Abstract][Full Text] [Related]
19. Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis.
van Schayck CP; Folgering H; Harbers H; Maas KL; van Weel C
Thorax; 1991 May; 46(5):355-9. PubMed ID: 1829865
[TBL] [Abstract][Full Text] [Related]
20. Bronchodilating drugs and airway reactivity.
Guerrin F; Robin H; Lahoutte C; Voisin C
Eur J Respir Dis Suppl; 1980; 106():71-5. PubMed ID: 6110561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
